bioRxivMicrobiologyPreprint
Sulbactam-mediated inhibition of TEM-1 β-lactamase increases specific yields of ampicillin-resistant plasmids
Abstract
Ampicillin resistance is the most widely used selection marker in molecular biology. Most ampicillin-resistant plasmids originate from highly active TEM-1 {beta}-lactamase cassette which causes very fast antibiotic decay and negatively affects long-term plasmid retention. The present work proposes a method of controlling the {beta}-lactamase activity by the addition of an irreversible {beta}-lactamase inhibitor. The positive effect of a {beta}-lactamase inhibitor, specifically sulbactam, on plasmid retention is confirmed by much higher specific plasmid yields: 4-8 times higher titres in shake-flask and almost 3 times higher in bioreactor scales were observed. Among all commercially available {beta}-lactamase inhibitors sulbactam provides the best combination of affordability and activity. The sulbactam addition is simple, fast and economic solution allowing to screen thousands of legacy pBR322 or pUC-derived plasmids harbouring TEM-1 {beta}-lactamase cassette without engineering their sequence.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Induction of AmpC-mediated-βlactam resistance requires a single lytic transglycosylase in Agrobacterium tumefaciens
W. Figueroa-Cuilan, M. Howell, … P. J. B. Brown·bioRxiv·Sep 10, 2020
- Plasmid-free cheater cells commonly evolve during laboratory growth
A. M. Bedore, C. M. Waters·bioRxiv·May 19, 2023
- Molecular Glue-like Degraders of TEM β-Lactamases by Periplasmic Protease DegP
Emilia K. Taylor, Patrícia Santos Barbosa, … Thomas Lanyon‐Hogg·Angewandte ChemiePeer-reviewed·Oct 30, 2026
- An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting
Addison M. Duda, Helena R. Ma, … Katherine J. Franz·ACS Infectious DiseasesPeer-reviewed·Jun 12, 2025
- Single-Domain Antibodies as Potent Inhibitors of Clinically Relevant β-Lactamases in Multidrug-Resistant Bacteria
Paloma Osset-Trénor, Markus Proft, Amparo Pascual‐Ahuir·Frontiers in MicrobiologyPeer-reviewed·Jun 10, 2026
- Disruption of undecaprenyl phosphate recycling suppresses ampC beta-lactamase induction in Pseudomonas aeruginosa
Karina Klycheva, Joël Gyger, … Coralie Fumeaux·PLoS PathogensPeer-reviewed·Oct 21, 2025